Callan Family Office, LLC Quest Diagnostics Inc Transaction History
Callan Family Office, LLC
- $3.14 Trillion
- Q3 2025
A detailed history of Callan Family Office, LLC transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Callan Family Office, LLC holds 2,309 shares of DGX stock, worth $316,540. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,309
Previous 3,447
33.01%
Holding current value
$316,540
Previous $619 Million
28.93%
% of portfolio
0.01%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding DGX
# of Institutions
1,132Shares Held
105MCall Options Held
472KPut Options Held
534K-
Vanguard Group Inc Valley Forge, PA14.3MShares$1.95 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY10.1MShares$1.38 Billion0.03% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD7.01MShares$960 Million0.14% of portfolio
-
State Street Corp Boston, MA5.22MShares$716 Million0.03% of portfolio
-
Jpmorgan Chase & CO New York, NY4.32MShares$592 Million0.04% of portfolio
About QUEST DIAGNOSTICS INC
- Ticker DGX
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 113,887,000
- Market Cap $15.6B
- Description
- Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...